First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature-Reference-Cited by-同舟云学术

First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature

Published:2022-08 Issue:4 Volume:5 Page:377-387
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Weiner Adam B.,Siebert Aisha L.,Fenton Sarah E.,Abida Wassim,Agarwal Neeraj,Davis Ian D.,Dorff Tanya B.,Gleave Martin,James Nicholas D.,Poon Darren M.C.,Suzuki Hiroyoshi,Sweeney Christopher J.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference65 articles.

1. Recent global patterns in prostate cancer incidence and mortality rates;Culp;Eur Urol,2020

2. Time trends and local variation in primary treatment of localized prostate cancer;Cooperberg;J Clin Oncol,2010

3. A risk-adjusted definition of biochemical recurrence after radical prostatectomy;Morgan;Prostate Cancer Prostatic Dis,2014

4. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer;Cornford;Eur Urol,2021

5. Advanced prostate cancer: AUA/ASTRO/SUO guideline part I;Lowrance;J Urol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer;Cancer Treatment Reviews;2024-01

2. Novel Multiparametric Magnetic Resonance Imaging-Based Deep Learning and Clinical Parameter Integration for the Prediction of Long-Term Biochemical Recurrence-Free Survival in Prostate Cancer after Radical Prostatectomy;Cancers;2023-06-29

3. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment;European Urology Open Science;2023-05

4. Managing Prostate Cancer Recurrence After Local Treatment: Balancing Benefits Against Risks in a Rapidly Changing Environment;European Urology Oncology;2022-08